Search

everythinglearnresearchcommunity

for

Search:↓

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.

Angiopoietin-1 helps hair follicle cells survive and grow, potentially treating hair loss.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Men with male pattern baldness have lower levels of the antioxidant PON1.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Ruxolitinib helped a patient with alopecia areata regrow hair.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Belatacept may be a promising treatment for alopecia areata.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

AP-1 controls tumor cell type by affecting key signaling pathways.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

A new gene mutation linked to a skin condition was found in a Spanish family.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Alopecia areata involves specific immune cells, offering potential treatment targets.

AH-001 could be a safer and more effective treatment for hair loss.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Targeting the AhR pathway may help treat alopecia areata.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

Vitamin D receptor gene changes don't affect alopecia areata risk.

New and known mutations in the hairless gene cause a hair loss condition called Atrichia with papular lesions.